Cargando…
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma
Vesiculoviruses are attractive oncolytic virus platforms due to their rapid replication, appreciable transgene capacity, broad tropism, limited preexisting immunity, and tumor selectivity through type I interferon response defects in malignant cells. We developed a synthetic chimeric virus (VMG) exp...
Autores principales: | Watters, Chelsae R., Barro, Oumar, Elliott, Natalie M., Zhou, Yumei, Gabere, Musa, Raupach, Elizabeth, Baker, Alexander T., Barrett, Michael T., Buetow, Kenneth H., Jacobs, Bertram, Seetharam, Mahesh, Borad, Mitesh J., Nagalo, Bolni Marius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033453/ https://www.ncbi.nlm.nih.gov/pubmed/36969560 http://dx.doi.org/10.1016/j.omto.2023.02.009 |
Ejemplares similares
-
Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018) -
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
por: Zhang, Yuguo, et al.
Publicado: (2022) -
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
por: Nagalo, Bolni Marius, et al.
Publicado: (2020) -
Oncolytic virotherapy in upper gastrointestinal tract cancers
por: Yokoda, Raquel, et al.
Publicado: (2018) -
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)